{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T11:37:11Z","timestamp":1787830631640,"version":"build-2784847793"},"reference-count":100,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.autrev.2016.07.014","type":"journal-article","created":{"date-parts":[[2016,8,2]],"date-time":"2016-08-02T22:31:17Z","timestamp":1470177077000},"page":"955-963","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":81,"title":["Critical review of the current recommendations for the treatment of systemic inflammatory rheumatic diseases during pregnancy and lactation"],"prefix":"10.1016","volume":"15","author":[{"given":"Roger A.","family":"Levy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guilherme R.","family":"de Jes\u00fas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nilson R.","family":"de Jes\u00fas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evandro M.","family":"Klumb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.autrev.2016.07.014_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2008.03.012","article-title":"A national study of the complications of lupus in pregnancy","volume":"199","author":"Clowse","year":"2008","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.autrev.2016.07.014_bb0010","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1186\/ar3227","article-title":"Managing pregnancy in inflammatory rheumatological diseases","volume":"13","author":"Jain","year":"2011","journal-title":"Arthritis Res Ther"},{"issue":"11","key":"10.1016\/j.autrev.2016.07.014_bb0015","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.2215\/CJN.00240110","article-title":"A systematic review and meta-analysis of pregnancy outcomes in patients with systemic lupus erythematosus and lupus nephritis","volume":"5","author":"Smyth","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.autrev.2016.07.014_bb0020","first-page":"943490","article-title":"Understanding and managing pregnancy in patients with lupus","volume":"2015","author":"de Jesus","year":"2015","journal-title":"Autoimmune Dis"},{"issue":"2-3","key":"10.1016\/j.autrev.2016.07.014_bb0025","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/s12026-014-8572-6","article-title":"Predictors of maternal and fetal complications in SLE patients: a prospective study","volume":"60","author":"Borella","year":"2014","journal-title":"Immunol Res"},{"issue":"7","key":"10.1016\/j.autrev.2016.07.014_bb0030","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1177\/0961203315572715","article-title":"Pregnancy and patients with preexisting lupus nephritis: 15years of experience at a single center in Korea","volume":"24","author":"Koh","year":"2015","journal-title":"Lupus"},{"issue":"5","key":"10.1016\/j.autrev.2016.07.014_bb0035","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.autrev.2014.12.011","article-title":"State of the art: reproduction and pregnancy in rheumatic diseases","volume":"14","author":"\u00d8stensen","year":"2015","journal-title":"Autoimmun Rev"},{"issue":"6","key":"10.1016\/j.autrev.2016.07.014_bb0040","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1002\/art.34350","article-title":"Brief report: successful pregnancies but a higher risk of preterm births in patients with systemic sclerosis: an Italian multicenter study","volume":"64","author":"Taraborelli","year":"2012","journal-title":"Arthritis Rheum"},{"issue":"12","key":"10.1016\/j.autrev.2016.07.014_bb0045","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1177\/0961203314529172","article-title":"The use of angiogenic and antiangiogenic factors in the differential diagnosis of pre-eclampsia, antiphospholipid syndrome nephropathy and lupus nephritis","volume":"23","author":"de Jesus","year":"2014","journal-title":"Lupus"},{"issue":"9","key":"10.1016\/j.autrev.2016.07.014_bb0050","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1093\/rheumatology\/ker105","article-title":"Causes and management of infertility in systemic lupus erythematosus","volume":"50","author":"Hickman","year":"2011","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"10.1016\/j.autrev.2016.07.014_bb0055","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/art.21859","article-title":"Childbearing decisions and family size among women with rheumatoid arthritis","volume":"55","author":"Katz","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.autrev.2016.07.014_bb0060","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1002\/acr.21593","article-title":"Effects of infertility, pregnancy loss, and patient concerns on family size of women with rheumatoid arthritis and systemic lupus erythematosus","volume":"64","author":"Clowse","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"10","key":"10.1016\/j.autrev.2016.07.014_bb0065","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1136\/annrheumdis-2014-205383","article-title":"Fertility in women with rheumatoid arthritis: influence of disease activity and medication","volume":"74","author":"Brouwer","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"10.1016\/j.autrev.2016.07.014_bb0070","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1002\/acr.20323","article-title":"Maintenance of fertility in patients with rheumatic diseases needing antiinflammatory and immunosuppressive drugs","volume":"62","author":"Silva","year":"2010","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.autrev.2016.07.014_bb0075","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s13023-015-0332-8","article-title":"Immunosuppressive drugs and fertility","volume":"10","author":"Leroy","year":"2015","journal-title":"Orphanet J Rare Dis"},{"issue":"4","key":"10.1016\/j.autrev.2016.07.014_bb0080","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.rbr.2014.05.008","article-title":"Anti-Mullerian hormone levels as a predictor of ovarian reserve in systemic lupus erythematosus patients: a review","volume":"55","author":"Gasparin","year":"2015","journal-title":"Rev Bras Reumatol"},{"issue":"12","key":"10.1016\/j.autrev.2016.07.014_bb0085","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1002\/acr.20605","article-title":"Ovarian reserve diminished by oral cyclophosphamide therapy for granulomatosis with polyangiitis (Wegener's)","volume":"63","author":"Clowse","year":"2011","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"3","key":"10.1016\/j.autrev.2016.07.014_bb0090","first-page":"97","article-title":"Protective effect of GnRH analogues on the reproductive capacity of women with neoplasia or autoimmune disease who require chemotherapy. Final results of a phase ii clinical trial","volume":"146","author":"Gris-Martinez","year":"2016","journal-title":"Med Clin (Barc)"},{"issue":"11","key":"10.1016\/j.autrev.2016.07.014_bb0095","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1177\/0961203311409272","article-title":"Impact of systemic lupus erythematosus on ovarian reserve in premenopausal women: evaluation by using anti-Muellerian hormone","volume":"20","author":"Lawrenz","year":"2011","journal-title":"Lupus"},{"issue":"12","key":"10.1016\/j.autrev.2016.07.014_bb0100","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1089\/jwh.2013.4255","article-title":"Subclinical impairment of ovarian reserve in systemic lupus erythematosus patients with normal menstruation not using alkylating therapy","volume":"22","author":"Ma","year":"2013","journal-title":"J Womens Health (Larchmt)"},{"issue":"10","key":"10.1016\/j.autrev.2016.07.014_bb0105","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.3899\/jrheum.131360","article-title":"Reduced ovarian reserve in patients with takayasu arteritis","volume":"41","author":"Mont'Alverne","year":"2014","journal-title":"J Rheumatol"},{"issue":"9","key":"10.1016\/j.autrev.2016.07.014_bb0110","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1093\/rheumatology\/kev124","article-title":"Ovarian reserve alterations in premenopausal women with chronic inflammatory rheumatic diseases: impact of rheumatoid arthritis, Behcet's disease and spondyloarthritis on anti-Mullerian hormone levels","volume":"54","author":"Henes","year":"2015","journal-title":"Rheumatology (Oxford)"},{"issue":"8","key":"10.1016\/j.autrev.2016.07.014_bb0115","first-page":"461","article-title":"The role of autoimmunity in premature ovarian failure","volume":"13","author":"Ebrahimi","year":"2015","journal-title":"Iran J Reprod Med"},{"issue":"6","key":"10.1016\/j.autrev.2016.07.014_bb0120","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1093\/rheumatology\/keq458","article-title":"Fertility in women with chronic inflammatory arthritides","volume":"50","author":"Wallenius","year":"2011","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"10.1016\/j.autrev.2016.07.014_bb0125","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/1529-0131(200003)43:3<550::AID-ANR10>3.0.CO;2-Y","article-title":"Ovulation induction and in vitro fertilization in systemic lupus erythematosus and antiphospholipid syndrome","volume":"43","author":"Guballa","year":"2000","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.autrev.2016.07.014_bb0130","first-page":"46","article-title":"Thromboembolic complication after ovarian stimulation","volume":"141","author":"Hudak","year":"2016","journal-title":"Dtsch Med Wochenschr"},{"issue":"9","key":"10.1016\/j.autrev.2016.07.014_bb0135","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1093\/humrep\/det249","article-title":"GnRHa trigger and individualized luteal phase hCG support according to ovarian response to stimulation: two prospective randomized controlled multi-centre studies in IVF patients","volume":"28","author":"Humaidan","year":"2013","journal-title":"Hum Reprod"},{"issue":"10","key":"10.1016\/j.autrev.2016.07.014_bb0140","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1182\/blood-2011-03-340216","article-title":"Thrombophilia and outcomes of assisted reproduction technologies: a systematic review and meta-analysis","volume":"118","author":"Di Nisio","year":"2011","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.autrev.2016.07.014_bb0145","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1006\/jaut.2000.0416","article-title":"Management of patients with antiphospholipid antibodies undergoing in vitro fertilization","volume":"15","author":"Udoff","year":"2000","journal-title":"J Autoimmun"},{"issue":"12","key":"10.1016\/j.autrev.2016.07.014_bb0150","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1177\/0961203314527370","article-title":"Assisted reproductive technology in SLE and APS","volume":"23","author":"Levine","year":"2014","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2016.07.014_bb0155","series-title":"Medical eligibility criteria for contraceptive use","author":"World Health Organization","year":"2015"},{"issue":"6","key":"10.1016\/j.autrev.2016.07.014_bb0160","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1093\/rheumatology\/kes425","article-title":"Low risk of renal flares and negative outcomes in women with lupus nephritis conceiving after switching from mycophenolate mofetil to azathioprine","volume":"52","author":"Fischer-Betz","year":"2013","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"10.1016\/j.autrev.2016.07.014_bb0165","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.contraception.2014.04.011","article-title":"Effect of oral administration of a continuous 18day regimen of meloxicam on ovulation: experience of a randomized controlled trial","volume":"90","author":"Jesam","year":"2014","journal-title":"Contraception"},{"issue":"15","key":"10.1016\/j.autrev.2016.07.014_bb0170","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.2165\/11596240-000000000-00000","article-title":"Rheumatoid arthritis and pregnancy: safety considerations in pharmacological management","volume":"71","author":"Makol","year":"2011","journal-title":"Drugs"},{"issue":"3","key":"10.1016\/j.autrev.2016.07.014_bb0175","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1542\/peds.108.3.776","article-title":"Transfer of drugs and other chemicals into human milk","volume":"108","author":"Drugs AAoPCo.","year":"2001","journal-title":"Pediatrics"},{"issue":"11","key":"10.1016\/j.autrev.2016.07.014_bb0180","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1093\/rheumatology\/ker302","article-title":"Rheumatoid arthritis and pregnancy: evolution of disease activity and pathophysiological considerations for drug use","volume":"50","author":"Hazes","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2016.07.014_bb0185","article-title":"BSR and BHPR guideline on prescribing drugs in pregnancy and breastfeeding-Part II: analgesics and other drugs used in rheumatology practice","author":"Flint","year":"2016","journal-title":"Rheumatology (Oxford)"},{"issue":"16","key":"10.1016\/j.autrev.2016.07.014_bb0190","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.2169\/internalmedicine.50.5294","article-title":"Clopidogrel treatment during pregnancy: a case report and a review of literature","volume":"50","author":"De Santis","year":"2011","journal-title":"Intern Med"},{"issue":"1","key":"10.1016\/j.autrev.2016.07.014_bb0195","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s11926-011-0218-2","article-title":"Management of obstetric antiphospholipid syndrome","volume":"14","author":"de Jesus","year":"2012","journal-title":"Curr Rheumatol Rep"},{"issue":"9","key":"10.1016\/j.autrev.2016.07.014_bb0200","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/nrrheum.2012.106","article-title":"New insights into mechanisms of therapeutic effects of antimalarial agents in SLE","volume":"8","author":"Wallace","year":"2012","journal-title":"Nat Rev Rheumatol"},{"issue":"6","key":"10.1016\/j.autrev.2016.07.014_bb0205","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1191\/096120301678646137","article-title":"Hydroxychloroquine (HCQ) in lupus pregnancy: double-blind and placebo-controlled study","volume":"10","author":"Levy","year":"2001","journal-title":"Lupus"},{"issue":"2","key":"10.1016\/j.autrev.2016.07.014_bb0210","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.autrev.2004.11.009","article-title":"Safety of hydroxychloroquine in pregnant patients with connective tissue diseases. Review of the literature","volume":"4","author":"Costedoat-Chalumeau","year":"2005","journal-title":"Autoimmun Rev"},{"issue":"12","key":"10.1016\/j.autrev.2016.07.014_bb0215","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.3899\/jrheum.110686","article-title":"Ocular toxicity in children exposed in utero to antimalarial drugs: review of the literature","volume":"38","author":"Osadchy","year":"2011","journal-title":"J Rheumatol"},{"issue":"4","key":"10.1016\/j.autrev.2016.07.014_bb0220","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1191\/0961203304lu528oa","article-title":"Chloroquine gestational use in systemic lupus erythematosus: assessing the risk of child ototoxicity by pure tone audiometry","volume":"13","author":"Borba","year":"2004","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2016.07.014_bb0225","doi-asserted-by":"crossref","DOI":"10.1177\/0961203316629555","article-title":"Breastfeeding in mothers with systemic lupus erythematosus","author":"Noviani","year":"2016","journal-title":"Lupus"},{"issue":"2","key":"10.1016\/j.autrev.2016.07.014_bb0230","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/MJT.0b013e3182491e02","article-title":"Use of corticosteroids in early pregnancy is not associated with risk of oral clefts and other congenital malformations in offspring","volume":"21","author":"Bay Bjorn","year":"2014","journal-title":"Am J Ther"},{"issue":"10","key":"10.1016\/j.autrev.2016.07.014_bb0235","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1191\/0961203302lu263oa","article-title":"Antirheumatic drugs in pregnancy","volume":"11","author":"Harris","year":"2002","journal-title":"Lupus"},{"issue":"5","key":"10.1016\/j.autrev.2016.07.014_bb0240","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1097\/AOG.0b013e31825189dc","article-title":"Effect of antenatal corticosteroids on fetal growth and gestational age at birth","volume":"119","author":"Murphy","year":"2012","journal-title":"Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.autrev.2016.07.014_bb0245","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1002\/tera.10043","article-title":"Teratogen update: azathioprine and 6-mercaptopurine","volume":"65","author":"Polifka","year":"2002","journal-title":"Teratology"},{"issue":"1","key":"10.1016\/j.autrev.2016.07.014_bb0250","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/ibd.22948","article-title":"Systematic review and meta-analysis on the effects of thiopurines on birth outcomes from female and male patients with inflammatory bowel disease","volume":"19","author":"Akbari","year":"2013","journal-title":"Inflamm Bowel Dis"},{"issue":"7","key":"10.1016\/j.autrev.2016.07.014_bb0255","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1111\/j.1572-0241.2007.01216.x","article-title":"Therapeutic drug use in women with Crohn's disease and birth outcomes: a Danish nationwide cohort study","volume":"102","author":"Norgard","year":"2007","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"10.1016\/j.autrev.2016.07.014_bb0260","doi-asserted-by":"crossref","first-page":"196","DOI":"10.3109\/03009742.2011.626442","article-title":"Outcomes after anti-rheumatic drug use before and during pregnancy: a cohort study among 150,000 pregnant women and expectant fathers","volume":"41","author":"Viktil","year":"2012","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.autrev.2016.07.014_bb0265","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2015-208840","article-title":"The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation","author":"Gotestam Skorpen","year":"2016","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.autrev.2016.07.014_bb0270","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1089\/jwh.2008.0857","article-title":"Ovarian preservation by GnRH agonists during chemotherapy: a meta-analysis","volume":"18","author":"Clowse","year":"2009","journal-title":"J Womens Health (Larchmt)"},{"key":"10.1016\/j.autrev.2016.07.014_bb0275","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1001\/jama.1964.03060310023005","article-title":"Congenital anomalies probably induced by cyclophosphamide","volume":"188","author":"Greenberg","year":"1964","journal-title":"JAMA"},{"issue":"Suppl. 1","key":"10.1016\/j.autrev.2016.07.014_bb0280","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s00404-011-1859-0","article-title":"Successful pregnancy after cyclophosphamide therapy for lupus nephritis","volume":"283","author":"Lannes","year":"2011","journal-title":"Arch Gynecol Obstet"},{"issue":"3","key":"10.1016\/j.autrev.2016.07.014_bb0285","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/(SICI)1096-8628(19990917)86:3<237::AID-AJMG8>3.0.CO;2-V","article-title":"Apparent cyclophosphamide (cytoxan) embryopathy: a distinct phenotype?","volume":"86","author":"Enns","year":"1999","journal-title":"Am J Med Genet"},{"issue":"11","key":"10.1016\/j.autrev.2016.07.014_bb0290","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1177\/096120330101001110","article-title":"Cyclophosphamide therapy in a serious case of lupus nephritis during pregnancy","volume":"10","author":"Kart Koseoglu","year":"2001","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2016.07.014_bb0295","article-title":"BSR and BHPR guideline on prescribing drugs in pregnancy and breastfeeding-Part I: standard and biologic disease modifying anti-rheumatic drugs and corticosteroids","author":"Flint","year":"2016","journal-title":"Rheumatology (Oxford)"},{"issue":"7705","key":"10.1016\/j.autrev.2016.07.014_bb0300","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/S0140-6736(71)92474-3","article-title":"Cyclophosphamide in human milk","volume":"1","author":"Wiernik","year":"1971","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.autrev.2016.07.014_bb0305","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/bdra.23003","article-title":"Teratogen update: methotrexate","volume":"94","author":"Hyoun","year":"2012","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"issue":"5","key":"10.1016\/j.autrev.2016.07.014_bb0310","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1002\/art.38368","article-title":"Pregnancy outcome after methotrexate treatment for rheumatic disease prior to or during early pregnancy: a prospective multicenter cohort study","volume":"66","author":"Weber-Schoendorfer","year":"2014","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2016.07.014_bb0315","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.reprotox.2013.10.005","article-title":"Methotrexate embryopathy after exposure to low weekly doses in early pregnancy","volume":"43","author":"Martin","year":"2014","journal-title":"Reprod Toxicol"},{"key":"10.1016\/j.autrev.2016.07.014_bb0320","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.3899\/jrheum.140263","article-title":"Methotrexate use in a breastfeeding patient with rheumatoid arthritis","volume":"41","author":"Thorne","year":"2014","journal-title":"J Rheumatol"},{"issue":"2","key":"10.1016\/j.autrev.2016.07.014_bb0325","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/1096-9926(200102)63:2<106::AID-TERA1017>3.0.CO;2-R","article-title":"Teratogen update: reproductive risks of leflunomide (Arava); a pyrimidine synthesis inhibitor: counseling women taking leflunomide before or during pregnancy and men taking leflunomide who are contemplating fathering a child","volume":"63","author":"Brent","year":"2001","journal-title":"Teratology"},{"issue":"5","key":"10.1016\/j.autrev.2016.07.014_bb0330","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1002\/art.27358","article-title":"Birth outcomes in women who have taken leflunomide during pregnancy","volume":"62","author":"Chambers","year":"2010","journal-title":"Arthritis Rheum"},{"issue":"7","key":"10.1016\/j.autrev.2016.07.014_bb0335","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1002\/art.34419","article-title":"Pregnancy outcome in women exposed to leflunomide before or during pregnancy","volume":"64","author":"Cassina","year":"2012","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.autrev.2016.07.014_bb0340","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1097\/00007691-199512000-00023","article-title":"Mechanism of action of mycophenolate mofetil","volume":"17","author":"Ransom","year":"1995","journal-title":"Ther Drug Monit"},{"issue":"3","key":"10.1016\/j.autrev.2016.07.014_bb0345","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1002\/ajmg.a.35223","article-title":"Teratogenicity of mycophenolate confirmed in a prospective study of the European Network of Teratology Information Services","volume":"158a","author":"Hoeltzenbein","year":"2012","journal-title":"Am J Med Genet A"},{"issue":"1","key":"10.1016\/j.autrev.2016.07.014_bb0350","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.reprotox.2009.02.007","article-title":"Tetrada of the possible mycophenolate mofetil embryopathy: a review","volume":"28","author":"Merlob","year":"2009","journal-title":"Reprod Toxicol"},{"issue":"3","key":"10.1016\/j.autrev.2016.07.014_bb0355","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.coph.2013.03.004","article-title":"How safe are anti-rheumatic drugs during pregnancy?","volume":"13","author":"Ostensen","year":"2013","journal-title":"Curr Opin Pharmacol"},{"issue":"2","key":"10.1016\/j.autrev.2016.07.014_bb0360","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0089151","article-title":"Pregnancy outcomes in liver and cardiothoracic transplant recipients: a UK national cohort study","volume":"9","author":"Mohamed-Ahmed","year":"2014","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.autrev.2016.07.014_bb0365","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.3109\/14767058.2011.634461","article-title":"Pregnancy outcomes after kidney transplantation-immunosuppressive therapy comparison","volume":"25","author":"Perales-Puchalt","year":"2012","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"2","key":"10.1016\/j.autrev.2016.07.014_bb0370","doi-asserted-by":"crossref","first-page":"113","DOI":"10.2165\/11316280-000000000-00000","article-title":"Long-term neurodevelopment of children exposed in utero to ciclosporin after maternal renal transplant","volume":"12","author":"Nulman","year":"2010","journal-title":"Paediatr Drugs"},{"issue":"12","key":"10.1016\/j.autrev.2016.07.014_bb0375","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1097\/01.TP.0000066352.86763.D0","article-title":"Cyclosporine excretion into breast milk","volume":"75","author":"Moretti","year":"2003","journal-title":"Transplantation"},{"issue":"6","key":"10.1016\/j.autrev.2016.07.014_bb0380","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1111\/bcp.12122","article-title":"Tacrolimus placental transfer at delivery and neonatal exposure through breast milk","volume":"76","author":"Zheng","year":"2013","journal-title":"Br J Clin Pharmacol"},{"issue":"4","key":"10.1016\/j.autrev.2016.07.014_bb0385","doi-asserted-by":"crossref","first-page":"563","DOI":"10.2215\/CJN.06400612","article-title":"Breastfeeding and tacrolimus: serial monitoring in breast-fed and bottle-fed infants","volume":"8","author":"Bramham","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"10.1016\/j.autrev.2016.07.014_bb0390","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2010.02.063","article-title":"Pregnancy outcome after in utero exposure to colchicine","volume":"203","author":"Diav-Citrin","year":"2010","journal-title":"Am J Obstet Gynecol"},{"issue":"9","key":"10.1016\/j.autrev.2016.07.014_bb0395","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1111\/j.1365-2036.2011.04617.x","article-title":"High intra-uterine exposure to infliximab following maternal anti-TNF treatment during pregnancy","volume":"33","author":"Zelinkova","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"issue":"10","key":"10.1016\/j.autrev.2016.07.014_bb0400","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/j.cgh.2006.07.018","article-title":"Case report: evidence for transplacental transfer of maternally administered infliximab to the newborn","volume":"4","author":"Vasiliauskas","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.autrev.2016.07.014_bb0405","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1093\/rheumatology\/keq185","article-title":"Etanercept concentrations in maternal serum, umbilical cord serum, breast milk and child serum during breastfeeding","volume":"49","author":"Berthelsen","year":"2010","journal-title":"Rheumatology (Oxford, England)"},{"issue":"11","key":"10.1016\/j.autrev.2016.07.014_bb0410","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1136\/ard.2008.105924","article-title":"Etanercept during pregnancy and lactation in a patient with rheumatoid arthritis: drug levels in maternal serum, cord blood, breast milk and the infant's serum","volume":"68","author":"Murashima","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"10.1016\/j.autrev.2016.07.014_bb0415","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1517\/14740338.2014.973399","article-title":"Safety of anti-TNF therapy in inflammatory bowel disease during pregnancy","volume":"13","author":"Khan","year":"2014","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.autrev.2016.07.014_bb0420","doi-asserted-by":"crossref","first-page":"199","DOI":"10.2147\/IJWH.S6029","article-title":"The use of anti-TNFalpha medications for rheumatologic disease in pregnancy","volume":"2","author":"Clowse","year":"2010","journal-title":"Int J Womens Health"},{"issue":"2","key":"10.1016\/j.autrev.2016.07.014_bb0425","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2015.08.039","article-title":"Low Risk of Birth Defects for Infants Whose Mothers Are Treated With Anti-Tumor Necrosis Factor Agents During Pregnancy","volume":"14","author":"Broms","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"47","key":"10.1016\/j.autrev.2016.07.014_bb0430","doi-asserted-by":"crossref","first-page":"13205","DOI":"10.3748\/wjg.v21.i47.13205","article-title":"Safety of anti-tumor necrosis factor therapy during pregnancy in patients with inflammatory bowel disease","volume":"21","author":"Androulakis","year":"2015","journal-title":"World J Gastroenterol"},{"issue":"3","key":"10.1016\/j.autrev.2016.07.014_bb0435","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2015.12.003","article-title":"The Toronto Consensus Statements for the Management of Inflammatory Bowel Disease in Pregnancy","volume":"150","author":"Nguyen","year":"2016","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.autrev.2016.07.014_bb0440","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.crohns.2010.05.001","article-title":"Case report: fatal case of disseminated BCG infection in an infant born to a mother taking infliximab for Crohn's disease","volume":"4","author":"Cheent","year":"2010","journal-title":"J Crohns Colitis"},{"issue":"7750","key":"10.1016\/j.autrev.2016.07.014_bb0445","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/S0140-6736(72)90358-3","article-title":"Sterility and testicular atrophy related to cyclophosphamide therapy","volume":"1","author":"Fairley","year":"1972","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.autrev.2016.07.014_bb0450","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.1002\/1097-0142(19921201)70:11<2703::AID-CNCR2820701123>3.0.CO;2-X","article-title":"Impact of cyclophosphamide on long-term reduction in sperm count in men treated with combination chemotherapy for Ewing and soft tissue sarcomas","volume":"70","author":"Meistrich","year":"1992","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.autrev.2016.07.014_bb0455","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S0015-0282(16)38823-9","article-title":"Azoospermia caused by colchicine\u2014a case report","volume":"23","author":"Merlin","year":"1972","journal-title":"Fertil Steril"},{"issue":"25","key":"10.1016\/j.autrev.2016.07.014_bb0460","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1056\/NEJM197606172942508","article-title":"Colchicine and testicular function in man","volume":"294","author":"Bremner","year":"1976","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.autrev.2016.07.014_bb0465","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1111\/apt.13142","article-title":"Review article: the safety of therapeutic drugs in male inflammatory bowel disease patients wishing to conceive","volume":"41","author":"Sands","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.autrev.2016.07.014_bb0470","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1093\/rheumatology\/ket390","article-title":"No evidence for an increased risk of adverse pregnancy outcome after paternal low-dose methotrexate: an observational cohort study","volume":"53","author":"Weber-Schoendorfer","year":"2014","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"10.1016\/j.autrev.2016.07.014_bb0475","doi-asserted-by":"crossref","first-page":"628","DOI":"10.3899\/jrheum.100600","article-title":"Paternal exposure to methotrexate and pregnancy outcomes","volume":"38","author":"Beghin","year":"2011","journal-title":"J Rheumatol"},{"issue":"6","key":"10.1016\/j.autrev.2016.07.014_bb0480","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1136\/gut.22.6.452","article-title":"Incidence of sulphasalazine-induced male infertility","volume":"22","author":"Birnie","year":"1981","journal-title":"Gut"},{"issue":"10","key":"10.1016\/j.autrev.2016.07.014_bb0485","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1136\/gut.25.10.1078","article-title":"Reversible male infertility due to sulphasalazine: studies in man and rat","volume":"25","author":"O'Morain","year":"1984","journal-title":"Gut"},{"issue":"10","key":"10.1016\/j.autrev.2016.07.014_bb0490","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1136\/ard.2009.127423","article-title":"Effects of TNF antagonists on sperm characteristics in patients with spondyloarthritis","volume":"69","author":"Villiger","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.autrev.2016.07.014_bb0495","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.fertnstert.2013.10.048","article-title":"Influence of tumor necrosis factor alpha inhibitors on testicular function and semen in spondyloarthritis patients","volume":"101","author":"Ramonda","year":"2014","journal-title":"Fertil Steril"},{"issue":"5","key":"10.1016\/j.autrev.2016.07.014_bb0500","first-page":"765","article-title":"Impact of TNF-blocking agents on male sperm characteristics and pregnancy outcomes in fathers exposed to TNF-blocking agents at time of conception","volume":"30","author":"Puchner","year":"2012","journal-title":"Clin Exp Rheumatol"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997216301598?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997216301598?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,9]],"date-time":"2018-09-09T20:52:09Z","timestamp":1536526329000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997216301598"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":100,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["S1568997216301598"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2016.07.014","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Critical review of the current recommendations for the treatment of systemic inflammatory rheumatic diseases during pregnancy and lactation","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2016.07.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}